![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Steven Belenko, PhD1, Richard Dembo, PhD2, Doris Weiland, MA1, and Christopher Salvatore, MA1. (1) Department of Criminal Justice, Temple University, 5th Floor Gladfelter Hall, 1115 West Berks Street, Philadelphia, PA 19122, 215-204-2211, sbelenko@temple.edu, (2) University of South Florida, 4202 E. Fowler Avenue, CPR107, Tampa, FL 33620
Although prior research has indicated that incarcerated juvenile offenders represent a subpopulation at high risk for sexually transmitted infections (STIs), no data have been available on the prevalence of STIs and the risk factors associated with these infections for the much larger population of youth who are arrested but who receive community supervision instead of incarceration. In a NIDA-funded project in Hillsborough County (Tampa) FL, we are investigating the prevalence of Chlamydia and gonorrhea and associated risk factors among high risk youth recently arrested for delinquent offenses. This paper presents results from analyses of the relation between sexual risk behaviors and exposure to STI/HIV prevention services on STI prevalence among a sample of 443 female and 507 male delinquents. Gender-specific analyses include the effects on STI prevalence of age of sexual initiation, number of partners, condom use, and perceived vulnerability to STIs. Additional analyses investigate the protective effects of prior exposure to STI/HIV prevention services, disaggregated by type and amount of exposure, as well as the effects of prior STI testing experience. We find that the risk of STI is related to age at first intercourse, number of partners, and exposure to STI/HIV prevention services. Gender differences in these relationships are also noted. Implications for improving public health strategies to increase STI testing, prevention, and treatment among high-risk youth are also discussed.
Learning Objectives:
Keywords: STD, Adolescent Health
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA